Galyam_2001_Antisense.Nucleic.Acid.Drug.Dev_11_51

Reference

Title : Complex host cell responses to antisense suppression of ACHE gene expression - Galyam_2001_Antisense.Nucleic.Acid.Drug.Dev_11_51
Author(s) : Galyam N , Grisaru D , Grifman M , Melamed-Book N , Eckstein F , Seidman S , Eldor A , Soreq H
Ref : Antisense Nucleic Acid Drug Dev , 11 :51 , 2001
Abstract :

3'-End-capped, 20-mer antisense oligodeoxynucleotides (AS-ODN) protected with 2'-O-methyl (Me) or phosphorothioate (PS) substitutions were targeted to acetylcholinesterase (AChE) mRNA and studied in PC12 cells. Me-modified AS-ODN suppressed AChE activity up to 50% at concentrations of 0.02-100 nM. PS-ODN was effective at 1-100 nM. Both AS-ODN displayed progressively decreased efficacy above 10 nM. In situ hybridization and confocal microscopy demonstrated dose-dependent decreases, then increases, in AChE mRNA. Moreover, labeling at nuclear foci suggested facilitated transcription or stabilization of AChE mRNA or both under AS-ODN. Intracellular concentrations of biotinylated oligonucleotide equaled those of target mRNA at extracellular concentrations of 0.02 nM yet increased only 6-fold at 1 microM ODN. Above 50 nM, sequence-independent swelling of cellular, but not nuclear, volume was observed. Our findings demonstrate suppressed AChE expression using extremely low concentrations of AS-ODN and attribute reduced efficacy at higher concentrations to complex host cell feedback responses.

PubMedSearch : Galyam_2001_Antisense.Nucleic.Acid.Drug.Dev_11_51
PubMedID: 11258621

Related information

Citations formats

Galyam N, Grisaru D, Grifman M, Melamed-Book N, Eckstein F, Seidman S, Eldor A, Soreq H (2001)
Complex host cell responses to antisense suppression of ACHE gene expression
Antisense Nucleic Acid Drug Dev 11 :51

Galyam N, Grisaru D, Grifman M, Melamed-Book N, Eckstein F, Seidman S, Eldor A, Soreq H (2001)
Antisense Nucleic Acid Drug Dev 11 :51